Mechanism of Hepatocellular Dysfunction During Early Sepsis
- 1 April 1997
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 132 (4) , 364-370
- https://doi.org/10.1001/archsurg.1997.01430280038005
Abstract
Background: Hepatocellular dysfunction occurs at 1.5 hours after cecal ligation and puncture (CLP [ie, sepsis model]), despite normal cardiac output and hepatic perfusion. Objective: To determine whether proinflammatory cytokines such as tumor necrosis factor (TNF) and interleukin-6 (IL-6) are up-regulated before the occurrence of hepatocellular dysfunction during sepsis. Design, Intervention, and Main Outcome Measure: Rats were subjected to sepsis by CLP, followed by administration of normal saline solution, 3 mL/100 g of body weight, to these and animals undergoing sham operation. At 0.5, 1, 1.5, or 2 hours after CLP, circulating levels of TNF and IL-6 were measured by enzyme-linked immunosorbent assay and bioassay, respectively. In additional animals, Kupffer cells were isolated at 1, 2, or 5 hours after CLP or sham operation. Kupffer cell TNF and IL-6 messenger RNA levels were determined by reverse-transcription polymerase chain reaction technique. Results: Plasma levels of TNF and IL-6 increased significantly at 1.5 hours and persisted at 2 hours after CLP. Levels of TNF and IL-6 messenger RNA in Kupffer cells increased as early as 1 hour after CLP. The up-regulated gene expression also persisted at 2 and 5 hours after the onset of sepsis. Conclusions: We have previously shown that TNF-α infusion produces hepatocellular dysfunction and that pharmacological inhibition of TNF production prevents it. Since the present study demonstrated that upregulation of proinflammatory cytokine gene expression occurs before hepatocellular dysfunction during sepsis, TNF and/or IL-6 may be responsible for producing hepatocellular dysfunction. Thus, administration of pharmacologic agents that selectively block or inhibit proinflammatory cytokine release may be useful in preventing cellular dysfunction during early sepsis. Arch Surg. 1997;132:364-370Keywords
This publication has 15 references indexed in Scilit:
- Pentoxifylline Maintains Hepatocellular Function and Improves Cardiac Performance during Early SepsisThe Journal of Trauma: Injury, Infection, and Critical Care, 1997
- Inhibition of the Biologic Activity of Tumor Necrosis Factor Maintains Vascular Endothelial Cell Function during Hyperdynamic SepsisThe Journal of Trauma: Injury, Infection, and Critical Care, 1996
- MULTIPLE ORGAN FAILURE, MULTIPLE ORGAN DYSFUNCTION SYNDROME, AND THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME—WHERE DO WE STAND?Shock, 1994
- ANTI-TUMOR NECROSIS FACTOR ANTIBODY TREATMENT OF RECURRENT BACTEREMIA IN A BABOON MODELShock, 1994
- Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of PathogenesisAnnals of Internal Medicine, 1994
- Effects of tumor necrosis factor-α on glucose and albumin production in primary cultures of rat hepatocytesMetabolism, 1994
- Role of tumor necrosis factor-α in disease states and inflammationCritical Care Medicine, 1993
- The Complex Pattern of Cytokines in Sepsis Association Between Prostaglandins, Cachectin, and InterleukinsAnnals of Surgery, 1991
- Hepatic Extraction of Indocyanine Green Is Depressed Early in Sepsis Despite Increased Hepatic Blood Flow and Cardiac OutputArchives of Surgery, 1991
- Epidermal keratin gene expressed in embryos of Xenopus laevis.Proceedings of the National Academy of Sciences, 1985